Certain blood types in combination with Rh, race (Black patients and White patients), and pregnant or not pregnant demonstrated protection against the virus.
(Adobe Stock)
A new case-controlled study published recently in the America Journal of Infection Control (AJIC), demonstrates that positive results of SARS-CoV-2 are related to blood type, confirming previous research. Also, this study, investigated blood types for SARS-CoV-2 and correlation for disease acquisition in various sociodemographic groups including women of childbearing age, which confirms further and more recent research demonstrating that inequities within certain sociodemographic groups did exist. While this study validated protection for pregnant women against SARS-CoV-2, further and larger studies are needed.
“Our study team was able to replicate findings from studies performed earlier in the pandemic, which demonstrated that blood type can play a significant role in acquisition of SARS-CoV-2. We were also able to support findings from more recent research showing that social inequities, such as race and gender, contribute to an individual’s likelihood of contracting the disease,” Maria L. Vacca, MSN, RN, CIC, director of infection prevention at Thomas Jefferson University Hospitals Center City, and author of the study told Infection Control Today® (ICT®) in an exclusive interview. “While replication of findings performed from previous research studies is important, our research produced a novel finding, showing that pregnant women in our study group were significantly less likely to contract SARS-CoV-2 than non-pregnant women of childbearing age. This new information is very exciting and adds to the growing body of knowledge that currently exists regarding the virus.”
This institutional review board (IRB) approved study was conducted at the Jefferson University Hospitals located in New Jersey and Pennsylvania from March 2020 through March 2021. It consisted of 27,662 patients and reinforced initial international studies which revealed a significant correlation between blood type A and SARS-CoV-2 susceptibility.
"This article emphasizes 1 glaring aspect of health care brought to light during the pandemic—socioeconomic level and lack of adequate health care. Both were a wake-up call for society to finally act on this known disparity" said Sharon Ward-Fore, MS, MT(ASCP), CIC, FAPIC, an infection prevention consultant, located in Chicago, and a member of Infection Control Today’s® Editorial Advisory Board, told ICT® when she reviewed this research.
The inclusion criteria included 27,662 in-patients with blood type assessed who were tested for SARS-CoV-2. The study endpoints combined ABO, Rh, and (ACIM) with testing positivity. Inclusion criteria included all admitted adult patients, ages 18 years and older, who were tested for SARS-CoV-2 and had a recorded blood type upon admission. The first test for SARS-CoV-2 with a positive result was used for patients who had multiple SARS-CoV-2 tests, and all others excluded. Primary study end points combined ABO blood type and Rh with likelihood of testing positive and all-cause inpatient mortality (ACIM). Secondary end points included age, gender, race, and body mass index (BMI).
Of the patients included in the study:
In the patients who met the criteria, the investigators found following results:
Inclusion criteria included all admitted adult patients, ages 18 years and older, who were tested for SARS-CoV-2 and had a recorded blood type upon admission. The first test for SARS-CoV-2 with a positive result was used for patients who had multiple SARS-CoV-2 tests, and all others excluded. Primary study end points combined ABO blood type and Rh with likelihood of testing positive and (ACIM). Secondary end points included age, gender, race, and body mass index (BMI). There was a subgroup analysis focused on women of childbearing age and pregnancy status.
“More studies are warranted to confirm and further explore this topic. I would love to see more Infection Preventionists lead research studies around this and other topics they are passionate about, and believe it is an important and expanding role for our profession,” Vacca told ICT®.
The investigators also mentioned in the study, “More research is warranted … to explore if positivity is affected by physiological, social, or behavioral factors, or influenced by a combination of causes.”
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.